| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |